| Cohort 1 (plus HAL) | ||||||
---|---|---|---|---|---|---|---|
Patient identifier | NH-01 | NH-02 | NH-03 | NH-06 | TH-01 | Mean | (SD) |
Cumulative HAL use, number of sessions | Â | ||||||
 3 months (12 weeks) | 0 | 0 | 22 | 0 | 9 | 6.20 | (9.65) |
 9 months | 17 | 16 | 47 | 4 | 19 | 20.60 | (15.88) |
 15 months | 36 | 79 | 55 | 16 | 28 | 42.80 | (24.71) |
Characteristics of HAL session | Â | Â | Â | Â | Â | Â | Â |
 Total number of courses | 4 | 5 | 6 | 3 | 3 | 4.20 | (1.30) |
 Mean session interval entire treatment period (days) | 9.00 | 4.20 | 8.45 | 27.56 | 15.00 | 12.84 | (9.08) |
 Mean session interval within each course (days) | 1.62 | 2.78 | 2.37 | 8.57 | 3.03 | 3.67 | (2.79) |
2MWT change (m) | 20.56 | 24.36 | 46.69 | -14.61 | 75.50 | 30.50 | (33.39) |